---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-23-067953"
form_type: "8-K"
ticker: "HURA"
cik: "0001498382"
company_name: "TuHURA Biosciences, Inc./NV"
filed_at: "2023-12-05T23:59:59+00:00"
generated_at: "2026-06-07T17:58:11.282721+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Nasdaq extends Kintara's deadline to March 18, 2024 for stockholders' equity compliance

## Summary
- Original non-compliance notice received September 20, 2023 for $2.5M minimum stockholders' equity requirement.
- Extension granted December 4, 2023, conditioned on achieving milestones in compliance plan submitted November 6, 2023.
- If compliance not evidenced by March 18, 2024, Nasdaq may delist; company can appeal to hearings panel.
- No immediate effect on listing; KTRA shares continue trading on Nasdaq Capital Market.

## SEC filing metadata
- accession: 0000950170-23-067953
- form_type: 8-K
- ticker: HURA
- cik: 0001498382
- company_name: TuHURA Biosciences, Inc./NV
- filed_at: 2023-12-05T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 3.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1498382/000095017023067953/0000950170-23-067953-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1498382/000095017023067953/ktra-20231204.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-23-067953
- JSON: https://secwatch.observer/filing/0000950170-23-067953.json
- Plain text: https://secwatch.observer/filing/0000950170-23-067953.txt

## Key facts
- Listing & Compliance Notices
  TuHURA Biosciences, Inc./NV received a nasdaq deficiency notice notice regarding stockholders equity (rules 5550(b)).
  - Exchange: nasdaq
  - Notice: deficiency notice
  - Deficiency: stockholders equity
  - Rules: 5550(b)
  source text: November 6, 2023, the Company submitted to the Staff a plan to regain compliance with the Stockholders’ Equity Requirement. On December 4, 2023, the Staff provided notice (the “Notice”) to the Company that it granted an extension of up to 180 days from September 20, 2023, or through March 18, 2024, to regain compliance with the Stockholders’ Equity Requirement, conditioned upon the Company’s achievement of certain milestones included in the plan of compliance previously submitted to the Staff. If the Company fails to evidence compliance upon filing its periodic report for the quarter ending Ma
  evidence_url: https://www.sec.gov/Archives/edgar/data/1498382/000095017023067953/0000950170-23-067953-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.